Work

Abstract 4144219: Safety and Efficacy of Rechallenging Immune Checkpoint Inhibitors After Discontinuation Due to Immune-Associated Myocarditis in Cancer Patients

Year: 2024

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.150.suppl_1.4144219

Authors: Jian Zhang, Mengxiao Han, Zheng Li, Yan Wang, Leilei Cheng

Institutions: Fudan University, Zhongshan Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404359507

Cites:

Cited by:

Related to: 10